Antipsychotics: Neurobiological Bases for a Therapeutic Approach
| Autor: | Salih Gümrü, Feyza Aricioglu |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Mechanism (biology)
business.industry Dopaminergic Disease medicine.disease 030227 psychiatry 03 medical and health sciences Psychiatry and Mental health Therapeutic approach 0302 clinical medicine Neurotrophic factors Schizophrenia Neuroplasticity Medicine Pharmacology (medical) business Neuroscience 030217 neurology & neurosurgery Neuroinflammation |
| Zdroj: | Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology. 23:91-98 |
| ISSN: | 1302-9657 1017-7833 |
| DOI: | 10.5455/bcp.20130320010604 |
| Popis: | Studies on the pathophysiology of schizophrenia have become an adventure. It started with a simple pathological approach, focusing only on positive symptoms caused by dopaminergic hyperactivity in mesolimbic system and then branched out with contributions of many different components, including many receptors, various intracellular signaling pathways and gene-environment interactions. These new approaches have been useful in treating the negative symptoms and cognitive impairment observed in schizophrenia. Since there is a bulk of information on the mechanisms causing the disease, a proportional increase in the number of possible new treatment options has been proposed. The most challenging approaches in the disease mechanism address the glutamatergic system, neuroinflammation, neuroplasticity and neurotrophic factors, genetic factors and some intracellular signaling pathways. In this review, all of the above listed factors are discussed in detail. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|